Juvenile Idiopathic Arthritis (JIA) Registry

计划入组 849 人 · 首次发布于 2008 年 10 月 31 日

Adalimumab in JIA-associated Uveitis Stopping Trial

计划入组 87 人 · 首次发布于 2019 年 1 月 25 日

Serum Interleukin - 17A in Juvenile Idiopathic Arthritis

计划入组 78 人 · 首次发布于 2023 年 1 月 18 日

Jia Wei Xiao Yao Jiaonang

Guizhi Jia Shaoyao DahuangDecoction

Guizhi Jia Huangqi Decoction

Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

China

BeyondSpring

United States

LUZHOU LAO JIAO CO.，LTD

Biosimilar Switch in JIA Patients Shows Comparable Outcomes to Originator Maintenance

Hope Biosciences Receives FDA Authorization for Phase II JIA Stem Cell Trial

pGTI Applied in STAR-JIA Trial to Assess Steroid Toxicity in Children with Juvenile Idiopathic Arthritis